South State Corp Cybin Inc. Transaction History

South State Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 06, 2022	SELL	$0.74 - $1.22 $4,070 - $6,710	-5,500 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.13 - $2.31 $6,214 - $12,705	5,500 New	5,500 $7,000

109

243M

Ticker CYBN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 166,120,000
Market Cap $43.2M
Description
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...

Get notified when there are updates to the investment portfolio of South State Corp, based on Form 13F filings with the SEC.

Stay updated on South State Corp with notifications on news.